Kinaxis Inc. (TSE:KXS – Get Free Report) has been given an average rating of “Buy” by the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. Eight equities research analysts have rated the stock with a buy rating. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is C$210.56.
KXS has been the topic of several research analyst reports. National Bank Financial raised their price objective on Kinaxis from C$210.00 to C$245.00 and gave the company an “outperform” rating in a report on Monday, November 9th. BMO Capital Markets upped their target price on Kinaxis from C$195.00 to C$200.00 and gave the stock an “outperform” rating in a research note on Friday, August 7th. RBC Dominion Securities set a C$210.00 target price on Kinaxis and gave the stock an “outperform” rating in a research note on Friday, October 23rd. Stifel Nicolaus increased their target price on Kinaxis from C$200.00 to C$225.00 and gave the company a “buy” rating in a research report on Thursday, October 29th. Finally, Royal Bank Of Canada set a C$210.00 target price on Kinaxis and gave the company an “outperform” rating in a research report on Wednesday, August 26th.
View Our Latest Stock Report on Kinaxis
Kinaxis Price Performance
TSE:KXS opened at C$221.49 on Friday. The company has a quick ratio of 2.29, a current ratio of 1.81 and a debt-to-equity ratio of 11.18. Kinaxis has a 52 week low of C$117.22 and a 52 week high of C$234.37. The stock’s 50-day moving average price is C$193.10 and its 200-day moving average price is C$160.66. The stock has a market capitalization of C$6.00 billion, a PE ratio of 69.22, a price-to-earnings-growth ratio of 3.60 and a beta of 0.43.
Kinaxis (TSE:KXS – Get Free Report) last released its quarterly earnings results on Wednesday, November 4th. The company reported C$1.72 earnings per share for the quarter. The company had revenue of C$228.16 million during the quarter. Kinaxis had a return on equity of 22.26% and a net margin of 14.33%. As a group, equities analysts expect that Kinaxis will post 4.25 EPS for the current fiscal year.
Insider Activity at Kinaxis
In other Kinaxis news, insider David Peter Kelly sold 1,603 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of C$177.68, for a total transaction of C$284,821.04. Following the completion of the transaction, the insider directly owned 358 shares in the company, valued at approximately C$63,609.44. This represents a 81.74% decrease in their ownership of the stock. Also, insider Vasile Gelu Ticala sold 961 shares of the stock in a transaction on Monday, August 31st. The shares were sold at an average price of C$177.68, for a total transaction of C$170,750.48. Following the transaction, the insider directly owned 596 shares in the company, valued at approximately C$105,897.28. The trade was a 61.72% decrease in their ownership of the stock. Insiders sold a total of 10,076 shares of company stock worth $1,796,820 in the last quarter. 1.20% of the stock is owned by insiders.
Kinaxis Company Profile
Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains, and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption.
Featured Stories
- Five stocks we like better than Kinaxis
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Kinaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kinaxis and related companies with MarketBeat.com's FREE daily email newsletter.
